Evidence map›Paper›PMID 40075073›Full record

ArticleCell death & disease2025

CHCHD2 rescues the mitochondrial dysfunction in iPSC-derived neurons from patient with Mohr-Tranebjaerg syndrome.

Yihua Huang, Zirui Chen, Weiling Deng, Yawei Jiang, Yue Pan, Zhirong Yuan, Hailiang Hu, Yongming Wu, Yafang Hu

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Mitochondrial Microproteins: Emerging Regulators in Neurodevelopment and Neurodegeneration.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yihua HuangDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zirui ChenDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Weiling DengDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yawei JiangDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yue PanDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhirong YuanDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hailiang HuDepartment of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.ORCID http://orcid.org/0000-0001-9205-1603
Yongming WuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China. yongmingwu@smu.edu.cn.
Yafang HuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China. yafanghu@smu.edu.cn.ORCID http://orcid.org/0000-0001-6162-400X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82272991Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) 2019A1515011929Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) 2022A1515010013
6 · The paper itself

Abstract

Mohr-Tranebjaerg syndrome (MTS) is a rare X-linked recessive neurodegenerative disorder caused by mutations in the Translocase of Inner Mitochondrial Membrane 8A (TIMM8A) gene, which encodes TIMM8a, a protein localized to the mitochondrial intermembrane space (IMS). The pathophysiology of MTS remains poorly understood. To investigate the molecular mechanisms underlying MTS, we established induced pluripotent stem cells (iPSCs) from a male MTS patient carrying a novel TIMM8A mutation (c.225-229del, p.Q75fs95*), referred to as MTS-iPSCs. To generate an isogenic control, we introduced the same mutation into healthy control iPSCs (CTRL-iPSCs) using the Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 (CRISPR/Cas9), resulting in mutant iPSCs (MUT-iPSCs). We differentiated the three iPSC lines into neurons and evaluated their mitochondrial function and neuronal development. Both MTS- and MUT-iPSCs exhibited impaired neuronal differentiation, characterized by smaller somata, fewer branches, and shorter neurites in iPSC-derived neurons. Additionally, these neurons showed increased susceptibility to apoptosis under stress conditions, as indicated by elevated levels of cytochrome c and cleaved caspase-3. Mitochondrial function analysis revealed reduced protein levels and activity of complex IV, diminished ATP synthesis, and increased reactive oxygen species (ROS) generation in MTS- and MUT-neurons. Furthermore, transmission electron microscopy revealed mitochondrial fragmentation in MTS-neurons. RNA sequencing identified differentially expressed genes (DEGs) involved in axonogenesis, synaptic activity, and apoptosis-related pathways. Among these DEGs, coiled-coil-helix-coiled-coil-helix domain-containing 2 (CHCHD2), which encodes a mitochondrial IMS protein essential for mitochondrial homeostasis, was significantly downregulated in MTS-neurons. Western blot analysis confirmed decreased CHCHD2 protein levels in both MTS- and MUT-neurons. Overexpression of CHCHD2 rescued mitochondrial dysfunction and promoted neurite elongation in MTS-neurons, suggesting that CHCHD2 acts as a downstream effector of TIMM8a in the pathogenesis of MTS. In summary, loss-of-function of TIMM8a leads to a downstream reduction in CHCHD2 levels, collectively impairing neurogenesis by disrupting mitochondrial homeostasis. TIMM8a mutation (p.Q75fs95*) leads to mitochondrial dysfunction and neuronal defects in iPSC-derived neurons from patient with Mohr-Tranebjaerg syndrome, which are rescued by overexpression of CHCHD2. TIMM8a translocase of inner mitochondrial membrane 8a, CHCHD2 coiled-coil-helix-coiled-coil-helix domain-containing protein 2, MTS Mohr-Tranebjaerg syndrome, I mitochondrial complex I, II mitochondrial complex II, III mitochondrial complex III, IV mitochondrial complex IV, Q coenzyme Q10, Cyt c cytochrome c.

Indexed as

Induced Pluripotent Stem CellsMitochondriaMitochondrial ProteinsNeuronsOptic AtrophyTranscription FactorsApoptosisCell DifferentiationDNA-Binding ProteinsHumansMaleMitochondrial Precursor Protein Import Complex ProteinsMutationCHCHD2 protein, humanDNA-Binding ProteinsMitochondrial Precursor Protein Import Complex ProteinsMitochondrial ProteinsTIMM8A protein, humanTranscription Factors

Identifiers

PMID40075073
PMCPMC11903874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.